Sandelski Morgan M, Martini Deema, Kubon Todd M, Gion Greg G, Pittman Amy L
Department of Otolaryngology Head and Neck Surgery, Loyola University Medical Center, Maywood, IL 60153, USA;
Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA;
Craniomaxillofac Trauma Reconstr. 2025 Feb 18;18(1):16. doi: 10.3390/cmtr18010016. eCollection 2025 Mar.
Osseointegrated implants outside of dental restoration remain an integral area of facial reconstruction in which more outcomes data is needed. We aimed to describe our 13-year experience using osseointegrated implants for orbital, nasal, and auricular reconstruction, looking at general outcomes, including radiated and surgically manipulated bone.
This retrospective chart review covered demographics and outcomes from January 2008 to August 2021 in patients who underwent an orbital exenteration, partial or total rhinectomy, and partial or total auriculectomy with subsequent osseointegrated implant placement. We hypothesized radiation would increase the failure rate of implants and prostheses.
There were 79 implants placed in 27 patients, with over half of the patients requiring implants for reconstruction because of malignancy. The success rate was 86%. Complications were uncommon. Only 2 (7.4%) patients were unable to use their prosthesis. Prior radiation and surgery to the bone were associated with an increased risk of loss of implant ( = 0.008 and = 0.007, respectively) but not associated with other complications or prosthesis non-viability.
Osseointegrated implants are a reliable, permanent option for a realistic prosthesis. Radiation and prior surgery are significantly associated with an increased risk of implant failure but not associated with the inability to use the prosthesis. Regardless of prior treatments, bone-retained implants should be considered in facial reconstruction, especially after failing autologous repair or with concerns for cosmetic outcomes.
牙修复以外的骨整合植入物仍是面部重建的一个重要领域,在此领域需要更多的结果数据。我们旨在描述我们使用骨整合植入物进行眼眶、鼻和耳重建的13年经验,观察包括放疗和手术处理过的骨在内的总体结果。
这项回顾性图表审查涵盖了2008年1月至2021年8月期间接受眼眶内容剜除术、部分或全鼻切除术以及部分或全耳廓切除术并随后植入骨整合植入物的患者的人口统计学和结果。我们假设放疗会增加植入物和假体的失败率。
27例患者共植入79枚植入物,超过半数患者因恶性肿瘤需要植入物进行重建。成功率为86%。并发症不常见。只有2例(7.4%)患者无法使用其假体。先前对骨进行放疗和手术与植入物丢失风险增加相关(分别为P = 0.008和P = 0.007),但与其他并发症或假体无法使用无关。
骨整合植入物是用于逼真假体的可靠、永久性选择。放疗和先前手术与植入物失败风险增加显著相关,但与无法使用假体无关。无论先前的治疗如何,在面部重建中都应考虑骨保留植入物,尤其是在自体修复失败或对美容效果有顾虑的情况下。